Meyka Pro banner
Centessa Pharmaceuticals plc

Stay Updated with the Latest Centessa Pharmaceuticals plc CNTA News in Real Time

Find CNTA news now at Meyka AI. Stay informed with the latest Centessa Pharmaceuticals plc stocks updates, including price news, market analysis, and expert insights.

CNTANASDAQ
HealthcareBiotechnology
$40.50
$0.00(0.00%)
U.S. Market opens in 62h 17m
Trump Imposes 12.5% Tariff on Australian Exports From July 25
📅 4 hours ago

Trump Imposes 12.5% Tariff on Australian Exports From July 25

Trump’s new 12.5% tariff on Australian exports takes effect July 25, replacing temporary 10% duty. Australia disputes forced labour claims and calls tariffs unjustified.

Read more 12
HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership
📅 8 hours ago

HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership

HSBC agreed to sell its Singapore life and health insurance business to Allianz on July 24, 2026. The deal values HSBC Life Singapore at S$2.7 billion, or roughly £1.6 billion. It will also enter a 15-year exclusive bancassurance partnership with the German insurer. The transaction generates a pre-tax gain of $1.8 billion and lifts HSBC’s…

Read more 12
Barclays Plc Trading Chief Pushes Team to Close Gap With Wall Street
📅 12 hours ago

Barclays Plc Trading Chief Pushes Team to Close Gap With Wall Street

Wall Street banks continue to widen their lead in global trading, increasing the pressure on European competitors. On July 24, 2026, reports said Barclays Plc’s trading chief asked staff to narrow the performance gap with major U.S. banks after another strong quarter for the industry.  Higher market volatility, steady deal activity, and strong client demand…

Read more 12
Generic Zyrtec Recalled Over Heartburn Drug Mix-Up, July 23
📅 18 hours ago

Generic Zyrtec Recalled Over Heartburn Drug Mix-Up, July 23

Generic Zyrtec recalled nationwide for cross-contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Call Rising Pharma at 1-844-874-7464.

Read more 12
Generic Zyrtec Recalled Over Ranitidine Contamination Risk July 23
📅 1 day ago

Generic Zyrtec Recalled Over Ranitidine Contamination Risk July 23

Generic Zyrtec cetirizine tablets recalled nationwide due to cross-contamination with ranitidine heartburn drug. Four lot numbers affected, expiring October 2028. No adverse events reported yet.

Read more 12
Ryanair (NASDAQ: RYAAY) Shares Drop 7% After Q1 Profit Miss and Weak Q2 Fare Outlook
📅 4 days ago

Ryanair (NASDAQ: RYAAY) Shares Drop 7% After Q1 Profit Miss and Weak Q2 Fare Outlook

On 20 July 2026, Ryanair (NASDAQ: RYAAY) shares fell about 7% after Europe’s largest low-cost airline reported quarterly profit that came in below market expectations and warned that summer ticket prices would stay below last year’s levels.  Passenger traffic continued to grow, but weaker fares and higher fuel costs put pressure on earnings. The results…

Read more 12
Caliber Mining IPO Sees Early Bids on Day 1; ₹135 Crore Anchor Book Backed by Abakkus and Helios
📅 7 days ago

Caliber Mining IPO Sees Early Bids on Day 1; ₹135 Crore Anchor Book Backed by Abakkus and Helios

The Caliber Mining IPO opened for public subscription on July 17, 2026. The Maharashtra-based coal mining and logistics firm is raising ₹450 crore through this mainboard offering. Ahead of the launch, the company secured ₹134.99 crore from anchor investors on July 16. Abakkus and Helios Mutual Fund led the anchor round, signaling strong institutional confidence…

Read more 12
ME Group (LSE: MEGP) Surges 13% After Reaffirming Full-Year Profit Outlook Despite April Slowdown 
📅 11 days ago

ME Group (LSE: MEGP) Surges 13% After Reaffirming Full-Year Profit Outlook Despite April Slowdown 

On 13 July 2026, ME Group International plc (LSE: MEGP) shares climbed about 13% after the company repeated its full-year profit guidance, even though trading slowed during April. Investors took the update as a sign that the weaker month did not reflect the company’s overall performance. Trading improved from May, while the Wash.ME laundry business…

Read more 12
AstraZeneca Shares Plunge 7.4% After Heart Drug Trial Fails—July 10
📅 14 days ago

AstraZeneca Shares Plunge 7.4% After Heart Drug Trial Fails—July 10

AstraZeneca stock fell 7.4% after Wainua heart drug trial missed primary goal. Jefferies models $2.5B sales loss. Meyka grades AZN B+, forecasts $131.71 by year-end.

Read more 12

CNTA News FAQ